NovoCure (NVCR) Inventory Average (2015 - 2026)

NovoCure (NVCR) has reported Inventory Average for 12 consecutive years, with $42.8 million the latest figure, recorded in Q2 2026.

• Quarterly Inventory Average rose 7.53% year-over-year to $42.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $42.8 million (up 7.53% YoY) and the FY2025 annual result came in at $38.1 million, up 4.04% from the prior year.
• Inventory Average climbed to $42.8 million in Q2 2026 per NVCR's latest filing, from $42.3 million in the prior quarter.
• Over the last five years, Inventory Average for NVCR reached as high as $42.8 million in Q2 2026 and fell as low as $26.8 million in Q1 2022.
• A 5-year average of $36.0 million and a median of $37.4 million in 2023 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2023 — Inventory Average jumped 33.45% — and 2025, when it decreased 7.44%.
• Year by year, Inventory Average stood at $28.1 million in 2022, then soared by 33.45% to $37.5 million in 2023, then retreated by 1.04% to $37.1 million in 2024, then gained by 8.13% to $40.1 million in 2025, then grew by 6.82% to $42.8 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $42.8 million, $42.3 million, and $40.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.